Oral neutrophil Levels Identified as Potential Biomarker for Diagnosing and Grading Periodontitis: Study

Published On 2025-07-11 15:00 GMT   |   Update On 2025-07-11 15:00 GMT
Advertisement

Researchers have found in a new study that Oral polymorphonuclear neutrophil (oPMN) levels can help distinguish between grade B and C periodontitis and correlate with key periodontal pathogens (Pg and Pi). This indicates that they may be potentially used as a valuable biomarker for diagnosis and risk assessment of disease progression.

Oral polymorphonuclear neutrophil (oPMN) levels are potential biomarkers for differentiating between stages and grades of periodontitis. We compared the diagnostic utility of oPMN levels with bleeding on probing percentage (BOP%) and microbial load in high-risk patients with periodontitis. Sixty-two subjects were divided into four categories based on periodontitis stage and grade: stage II periodontitis (S2P, n = 19), stage III periodontitis (S3P, n = 43), grade B periodontitis (GBP, n = 34), and grade C periodontitis (GCP, n = 28). Clinical parameters included probing depth (PD), BOP%, and clinical attachment loss (CAL). Associations between oPMN levels and BOP% were compared to periodontitis stage and grade, and the presence of the periodontal pathogens Porphyromonas gingivalis (Pg), Treponema denticola (Td), Tannerella forsythia (Tf), Aggregatibacter actinomycetemcomitans, and Prevotella intermedia (Pi) in the gingivocrevicular fluid (GCF). Both oPMN levels and BOP% were associated with increasing stage and grade of periodontitis; however, better sensitivity, specificity, and predictive values for differentiating between GBP versus GCP were observed with oPMN. Significant positive associations were found between oPMN level and the detection of Pg and Pi. OPMN level can be used to differentiate between grade B and C periodontitis. Likewise, the presence of periodontal pathogens Pg and Pi correlated with the oPMN level. Given these findings, oPMN level may be useful as a multipurpose clinical biomarker in terms of diagnosing periodontitis and determining the risk of disease progression. Periodontitis is a serious gum disease that can lead to tooth loss and is linked to other health issues. Currently, bleeding of the gums after probing is one method used to assess the disease activity, but this method is not always accurate. In this study, we investigated whether counting a type of immune cell called oral neutrophil found in saliva could provide a better way to detect and measure the severity of periodontitis. We examined 62 patients with different stages and grades of the disease. We found that the number of oral neutrophils was a better tool for identifying more severe cases and those at a higher risk for future breakdown than gum bleeding. We also found that higher levels of neutrophils were linked to the presence of harmful bacteria that cause periodontitis. These findings suggest that measuring oral neutrophils could be a more reliable way to diagnose and monitor periodontitis, helping dentists identify severe cases earlier and treat patients more effectively. This method could improve how we understand and manage gum disease, leading to better patient-centered outcomes.


Reference:

Prete BRJ, Barbour A, Sun C, Tenenbaum HC, Goldberg MB, Glogauer M. Prognostic utility of oral neutrophil counts in high-risk periodontitis: A retrospective study. J Periodontol. 2025; 1-14. https://doi.org/10.1002/jper.11360

Keywords:

Oral, neutrophil, Levels, Identified, Potential, Biomarker, Diagnosing, Grading, Periodontitis, Study, Prete BRJ, Barbour A, Sun C, Tenenbaum HC, Goldberg MB, Glogauer M




Tags:    
Article Source : Journal of Periodontology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News